Serum MicroRNA-21 as a Biomarker for Allergic Inflammatory Disease in Children

Deepali V. Sawant, Weiguo Yao, Zachary Wright, Cindy Sawyers, Robert Tepper, Sandeep Gupta, Mark Kaplan, Alexander Dent

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

MicroRNAs (miRs) have emerged as useful biomarkers for different disease states, including allergic inflammatory diseases such as asthma and eosinophilic esophagitis (EoE). Serum miRs are a possible non-invasive method for diagnosis of such diseases. We focused on microRNA-21 (miR-21) levels in serum, in order to assess the feasibility of using this gene as a non-invasive biomarker for these diseases in the clinic, as well as to better understand the expression pattern of miR-21 in allergic inflammation. We used quantitative PCR (QPCR) to assay miR-21 and other control miRs in esophageal biopsies from EoE patients and serum samples from EoE and asthma patients. Serum levels of miR-21 were significantly elevated in patients with asthma, whereas serum miR-21 levels were not associated with the presence of allergen-specific IgE (i.e. atopy). Esophageal biopsies showed a large elevation of miR-21 in EoE and an increase in miR-21 in EoE serum. Control U6 miR did not vary between asthma and control patients, however EoE serum had significantly decreased U6 microRNA compared to controls. The decreased U6 in EoE sera did not completely account for the relative increase in miR-21 in the sera of EoE patients. We report for the first time that miR-21 is elevated in the sera of both asthma and EoE patients. We find no relation between serum miR-21 levels and atopy. Our results thus suggest miR-21 is a novel biomarker for human allergic inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)36-40
Number of pages5
JournalMicroRNA (Shāriqah, United Arab Emirates)
Volume4
Issue number1
StatePublished - Jan 1 2015

Fingerprint

MicroRNAs
Eosinophilic Esophagitis
Biomarkers
Serum
Asthma
Biopsy
Allergens
Immunoglobulin E

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Serum MicroRNA-21 as a Biomarker for Allergic Inflammatory Disease in Children. / Sawant, Deepali V.; Yao, Weiguo; Wright, Zachary; Sawyers, Cindy; Tepper, Robert; Gupta, Sandeep; Kaplan, Mark; Dent, Alexander.

In: MicroRNA (Shāriqah, United Arab Emirates), Vol. 4, No. 1, 01.01.2015, p. 36-40.

Research output: Contribution to journalArticle

@article{7a10f30962ec4e0e848be83b5a93b274,
title = "Serum MicroRNA-21 as a Biomarker for Allergic Inflammatory Disease in Children",
abstract = "MicroRNAs (miRs) have emerged as useful biomarkers for different disease states, including allergic inflammatory diseases such as asthma and eosinophilic esophagitis (EoE). Serum miRs are a possible non-invasive method for diagnosis of such diseases. We focused on microRNA-21 (miR-21) levels in serum, in order to assess the feasibility of using this gene as a non-invasive biomarker for these diseases in the clinic, as well as to better understand the expression pattern of miR-21 in allergic inflammation. We used quantitative PCR (QPCR) to assay miR-21 and other control miRs in esophageal biopsies from EoE patients and serum samples from EoE and asthma patients. Serum levels of miR-21 were significantly elevated in patients with asthma, whereas serum miR-21 levels were not associated with the presence of allergen-specific IgE (i.e. atopy). Esophageal biopsies showed a large elevation of miR-21 in EoE and an increase in miR-21 in EoE serum. Control U6 miR did not vary between asthma and control patients, however EoE serum had significantly decreased U6 microRNA compared to controls. The decreased U6 in EoE sera did not completely account for the relative increase in miR-21 in the sera of EoE patients. We report for the first time that miR-21 is elevated in the sera of both asthma and EoE patients. We find no relation between serum miR-21 levels and atopy. Our results thus suggest miR-21 is a novel biomarker for human allergic inflammatory diseases.",
author = "Sawant, {Deepali V.} and Weiguo Yao and Zachary Wright and Cindy Sawyers and Robert Tepper and Sandeep Gupta and Mark Kaplan and Alexander Dent",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "4",
pages = "36--40",
journal = "MicroRNA (Shāriqah, United Arab Emirates)",
issn = "2211-5366",
publisher = "Bentham Science Publishers",
number = "1",

}

TY - JOUR

T1 - Serum MicroRNA-21 as a Biomarker for Allergic Inflammatory Disease in Children

AU - Sawant, Deepali V.

AU - Yao, Weiguo

AU - Wright, Zachary

AU - Sawyers, Cindy

AU - Tepper, Robert

AU - Gupta, Sandeep

AU - Kaplan, Mark

AU - Dent, Alexander

PY - 2015/1/1

Y1 - 2015/1/1

N2 - MicroRNAs (miRs) have emerged as useful biomarkers for different disease states, including allergic inflammatory diseases such as asthma and eosinophilic esophagitis (EoE). Serum miRs are a possible non-invasive method for diagnosis of such diseases. We focused on microRNA-21 (miR-21) levels in serum, in order to assess the feasibility of using this gene as a non-invasive biomarker for these diseases in the clinic, as well as to better understand the expression pattern of miR-21 in allergic inflammation. We used quantitative PCR (QPCR) to assay miR-21 and other control miRs in esophageal biopsies from EoE patients and serum samples from EoE and asthma patients. Serum levels of miR-21 were significantly elevated in patients with asthma, whereas serum miR-21 levels were not associated with the presence of allergen-specific IgE (i.e. atopy). Esophageal biopsies showed a large elevation of miR-21 in EoE and an increase in miR-21 in EoE serum. Control U6 miR did not vary between asthma and control patients, however EoE serum had significantly decreased U6 microRNA compared to controls. The decreased U6 in EoE sera did not completely account for the relative increase in miR-21 in the sera of EoE patients. We report for the first time that miR-21 is elevated in the sera of both asthma and EoE patients. We find no relation between serum miR-21 levels and atopy. Our results thus suggest miR-21 is a novel biomarker for human allergic inflammatory diseases.

AB - MicroRNAs (miRs) have emerged as useful biomarkers for different disease states, including allergic inflammatory diseases such as asthma and eosinophilic esophagitis (EoE). Serum miRs are a possible non-invasive method for diagnosis of such diseases. We focused on microRNA-21 (miR-21) levels in serum, in order to assess the feasibility of using this gene as a non-invasive biomarker for these diseases in the clinic, as well as to better understand the expression pattern of miR-21 in allergic inflammation. We used quantitative PCR (QPCR) to assay miR-21 and other control miRs in esophageal biopsies from EoE patients and serum samples from EoE and asthma patients. Serum levels of miR-21 were significantly elevated in patients with asthma, whereas serum miR-21 levels were not associated with the presence of allergen-specific IgE (i.e. atopy). Esophageal biopsies showed a large elevation of miR-21 in EoE and an increase in miR-21 in EoE serum. Control U6 miR did not vary between asthma and control patients, however EoE serum had significantly decreased U6 microRNA compared to controls. The decreased U6 in EoE sera did not completely account for the relative increase in miR-21 in the sera of EoE patients. We report for the first time that miR-21 is elevated in the sera of both asthma and EoE patients. We find no relation between serum miR-21 levels and atopy. Our results thus suggest miR-21 is a novel biomarker for human allergic inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=85050578655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050578655&partnerID=8YFLogxK

M3 - Article

C2 - 25707810

AN - SCOPUS:85050578655

VL - 4

SP - 36

EP - 40

JO - MicroRNA (Shāriqah, United Arab Emirates)

JF - MicroRNA (Shāriqah, United Arab Emirates)

SN - 2211-5366

IS - 1

ER -